Company Search:
Advanced Search
Sponsored Links
AC Immune SA Company Snapshot
AC Immune SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares AC Immune SA with three other companies in this sector in UNITED STATES : Voyager Therapeutics Inc (2019 sales of $104.39 million of which 100% was Clinical-stage gene therapy company), Adaptive Biotechnologies Corp ($85.07 million of which 100% was Biotechnology & Medical Research), and Recro Pharma Inc ($99.22 million of which 100% was CDMO).

Sales Analysis. Sales increased substantially in 2019: AC Immune SA reported sales of $111.79 million for the year ending December of 2019. This represents an increase of 1,418.0% versus 2018, when the company's sales were $7.36 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
AC Immune SA
  Stock Performance Chart for AC Immune SA
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 4.99
(Figures in U.S. Dollars)
1 Week 2.3%   13 Weeks 4.3%  
4 Weeks -27.7%   52 Weeks -10.1%  
AC Immune SA Key Data:
  Ticker: ACIU Country: Switzerland
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 111,788,749
(Year Ending Jan 2020).
Employees: 132
  Currency: U.S. Dollars Market Cap: 358,578,561
  Fiscal Yr Ends: December Shares Outstanding: 71,859,431
  Share Type: Common Closely Held Shares: 33,711,360
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.